Ovide
NDC Package 51672-5276-4

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

This product is EXCLUDED from the official NDC directory because the listing data was discontinued by the firm.

Ovide is a medication used to treat head lice, tiny insects that infest and irritate your scalp. Marketed by Taro Pharmaceuticals Usa, Inc., this product is identified by NDC 51672-5276 and is authorized under FDA application NDA018613.

Identification & Billing

NDC Package Code
51672-5276-4
Package Description
1 BOTTLE in 1 CARTON / 59 mL in 1 BOTTLE
Product Code
51672-5276
11-Digit Billing Format
51672527604
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.

Clinical Specifications

Proprietary Name
Ovide
Dosage Form
-
Usage Information
This medication is used to treat head lice, tiny insects that infest and irritate your scalp. Malathion belongs to a class of drugs known as organophosphates. It works by paralyzing and killing lice and their eggs (nits).

Regulatory & Marketing

Labeler Name
Taro Pharmaceuticals Usa, Inc.
FDA Application #
NDA018613
Marketing Category
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date
08-02-1982
End Marketing Date
01-17-2020
Listing Expiration
01-17-2020
Exclude Flag
D
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 51672-5276-4 identifies a specific commercial package of 1 bottle in 1 carton / 59 ml in 1 bottle of Ovide, labeled by Taro Pharmaceuticals Usa, Inc.. This is formulated for use and contains as the active substance.

Is this product currently listed with the FDA?

This product code is currently listed as inactive or excluded from the primary directory. It was introduced to the market by Taro Pharmaceuticals Usa, Inc. on August 02, 1982. The current certification is valid through January 17, 2020.

What are the primary indications for this medication?

This medication is used to treat head lice, tiny insects that infest and irritate your scalp. Malathion belongs to a class of drugs known as organophosphates. It works by paralyzing and killing lice and their eggs (nits).

How is this Taro Pharmaceuticals Usa, Inc. product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 51672527604. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-4-1)
51672-5276-4
11-Digit CMS (5-4-2)
51672-5276-04

Note: The zero is added to the Package segment to maintain the 5-4-2 structure.